1)Shimokawa H, et al:Heart failure as a general pandemic in Asia. Eur J Heart Fail 17:884-892, 2015
2)Yancy CW, et al:2017 ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure:A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Circulation 136:e137-e161, 2017
3)平岡栄治:【コラム】心不全患者で注意すべき薬物.Intensivist 2:836-840, 2010
4)Wei L, et al:Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease. Ann Intern Med 141:764-770, 2004
5)Amabile CM, Spencer AP:Keeping your patient with heart failure safe:A review of potentially dangerous medications. Arch Intern Med 164:709-720, 2004
6)Gislason GH, et al:Increased mortality and cardiovascular morbidity associated with use of nonsteroidal anti-inflammatory drugs in chronic heart failure. Arch Intern Med 169:141-149, 2009
7)Starling RC, Young JB:Tolvaptan in acute heart failure:Time to move on. J Am Coll Cardiol 69:1407-1408, 2017
8)Sudore RL, et al:Defining advance care planning for adults:A consensus definition from a multidisciplinary delphi panel. J Pain Symptom Manage 53:821-832. e1, 2017
9)Rietjens JAC, et al:Definition and recommendations for advance care planning:An international consensus supported by the European Association for Palliative Care. Lancet Oncol 18:e543-e551, 2017
10)Lu YW, et al:Lipid paradox in patients with acute myocardial infarction:Potential impact of malnutrition. Clin Nutr 38:2311-2318, 2019